Allianz stops fake insurance claims worth RM5.6mil


Flags with the logo of German insurer Allianz SE flutter prior to the company's annual general meeting in Munich, southern Germany, on May 3, 2017. / AFP PHOTO / Christof STACHE

KUALA LUMPUR: Allianz General Insurance Co (M) Bhd has stopped bogus insurance claims worth RM5.6mil between 2014 and 2016.

Head of claims Jayapragash Amblavanar said insurance fraud was a growing concern in Malaysia and the company reported an average of at least six fraud cases per month between 2014 and 2016.

“Single digit cases being reported in a month may not seem like a big problem to some, but it shows that insurance fraud is very real in Malaysia.

“So our commitment towards fraud control means being proactive and willing to take the necessary steps and put in place better controls to nip the problem in the bud,” he said in a statement on Tuesday.

Fighting off fraud enables better financial freedom and flexibility for Allianz to offer far better priced products to customers, he said, adding that it would also cement the company’s reputation as insurer that customers could trust to do the right thing. - Bernama

 

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Malaysia Airlines extends Airbus maintenance deal for A330ceo fleet
Asia stocks ride tech wave higher, oil slips again
Singapore's link to US stocks is struggling to attract traders
Indonesia's central bank holds rates steady, as expected
HLB Islamic channels RM138,600 to SURI entrepreneurs under iTEKAD
Oil falls on better supply outlook, hopes for US-Iran talks
EcoSys seeks to raise RM39.34mil from ACE Market IPO
Rehda seeks enhanced housing credit guarantee scheme, stamp duty relief in Budget 2027
Inno Therapeutics expands Malaysia's biotech ambitions
Trade surplus due to competitiveness

Others Also Read